Both in Biotechnology
Creative Medical Technology Holdings vs Liminatus Pharma
Over the past year CELZ returned −87.1% and LIMN returned −95.9%; their daily moves had a correlation of 0.05.
CELZ −87.1% LIMN −95.9%Growth of $1, one year, split-adjusted
| Metric | CELZ | LIMN |
|---|---|---|
| Price | $0.7200 | $2.92 |
| Market cap | $5.5M | $3.9M |
| Today | +4.32% | +1.04% |
| 1 month | −25.4% | −25.3% |
| 6 months | −67.6% | −71.4% |
| Year to date | −63.3% | −90.4% |
| 1 year | −86.0% | −95.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,822.2× | — |
| Net cash | $8.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 145.2% | 1,152.8% |
| Short % of float | 2.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).